One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort
Paul Loubet, Linda Wittkop, Läétitia Ninove, Mathieu Chalouni, Benoı̂t Barrou, Jean‐Yves Blay, Maryvonne Hourmant, Éric Thouvenot, Martine Laville, Bruno Laviolle, Jean‐Daniel Lelièvre, Jacques Morel, Stéphanie Nguyen Quoc, Jean‐Philippe Spano, Benjamin Terrier, Anne Thiébaut, Jean‐François Viallard, François Vrtovsnik, Sophie Circosta, Laure Esterle, Axel Levier, Philippe Vanhems, Éric Tartour, Béatrice Parfait, Xavier de Lamballerie, Odile Launay
Topics & Concepts
VaccinationMedicineImmunologyRegimenAntibodyImmune systemVaccine trialVirologyInternal medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations